evoke study semaglutide ameliorates Alzheimer's disease and restores oxytocin in APP/PS1 mice and human brain organoid models Novo Nordisk Alzheimer's drug trials

Improved Blood Sugar Control: Semaglutide may help improve blood sugar levels in people with type 2 diabetes

Subcutaneous Injection Guide | Investigational (Phase 3) Retatrutide Injection Sites Retatrutide (LY3437943) is an investigational triple-agonist GLP-1, GIP, and glucagon receptor agonist injected subcutaneously once a week

Once-weekly semaglutide 7.2 in adults with obesity (STEP UP): a randomised, controlled phase 3b trial

It is worth noting that upper respiratory tract infections and nasopharyngitis are commonly reported in clinical trials and these conditions may present with cough symptoms, which could explain coincidental cough in some patients taking tirzepatide

Investigations into the injuries are ongoing, including looking into reported cases in other jurisdictions